NCT00003535View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 1994

Primary Completion Date

January 31, 1998

Study Completion Date

January 31, 1998

Conditions
High Grade Glioma
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a recurrent/progressive high grade glioma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER